Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
Authors
Keywords
-
Journal
LIVER TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-17
DOI
10.1002/lt.26387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria
- (2020) Sunbin Ling et al. Annals of Translational Medicine
- Finding the Right Balance for the Use of Donation After Circulatory Death Livers for Patients With Hepatocellular Carcinoma
- (2020) David D. Lee et al. LIVER TRANSPLANTATION
- Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
- (2020) Kin Pan Au et al. World Journal of Gastrointestinal Surgery
- mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
- (2020) Andreas A. Schnitzbauer et al. ANNALS OF SURGERY
- OPTN/SRTR 2017 Annual Data Report: Liver
- (2019) W. R. Kim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
- (2018) Zhi-Hua Zhang et al. JOURNAL OF INVESTIGATIVE SURGERY
- Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
- (2018) Manuel Rodríguez-Perálvarez et al. TRANSPLANTATION
- Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
- (2017) Gonzalo Sapisochin et al. Nature Reviews Gastroenterology & Hepatology
- Safety of mTOR inhibitors in adult solid organ transplantation
- (2016) Pedro Ventura-Aguiar et al. Expert Opinion On Drug Safety
- Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma
- (2016) Elizabeth L. Yanik et al. LIVER TRANSPLANTATION
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma
- (2016) Shi-lei Xu et al. Clinics and Research in Hepatology and Gastroenterology
- Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation
- (2016) Chuan Shen et al. Oncotarget
- Hepatocellular carcinoma epidemiology
- (2014) Cristina Bosetti et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Everolimus-Based Immunosuppression in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Liver Transplantation: A Case Series
- (2014) A.O. Ferreiro et al. TRANSPLANTATION PROCEEDINGS
- Sirolimus Stimulates Vascular Stem/Progenitor Cell Migration and Differentiation Into Smooth Muscle Cells via Epidermal Growth Factor Receptor/Extracellular Signal–Regulated Kinase/β-Catenin Signaling Pathway
- (2013) Mei Mei Wong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
- (2012) K. V. Menon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
- (2010) V. P. Houde et al. DIABETES
- Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
- (2010) Marco Vivarelli et al. TRANSPLANTATION
- Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation
- (2009) Srinath Chinnakotla et al. LIVER TRANSPLANTATION
- Antitumoral Activity of Rapamycin Mediated Through Inhibition of HIF-1alpha and VEGF in Hepatocellular Carcinoma
- (2008) Wei Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
- (2008) Michael A. Zimmerman et al. LIVER TRANSPLANTATION
- Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria
- (2008) J. Zhou et al. TRANSPLANTATION PROCEEDINGS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started